Currently submitted to: JMIR Cancer
Date Submitted: Oct 19, 2025
Open Peer Review Period: Oct 21, 2025 - Dec 16, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A guided internet-delivered psychosocial intervention for women treated for gynecological cancer: a randomized crossover waiting list controlled trial.
ABSTRACT
Background:
Background:
The number of gynecological cancer survivors is increasing. Cancer survivors also live longer, often with long-term somatic and psychosocial late effects and challenges. Interventions to support adapting to life after illness, is thus paramount. One scalable method for including psychosocial interventions in the follow up for cancer survivors are guided internet-delivered interventions
Objective:
The aim of this study was to evaluate the feasibility of a guided psychosocial internet-delivered intervention for women treated for gynecological cancer. This included the participants’ evaluations of the program and the preliminary effects on quality of life and depression.
Methods:
Method: The intervention was evaluated in a randomized crossover waiting list controlled trial.
Results:
Results:
A total of 70 women was included in the trial. The findings show that the program was highly used, accepted and perceived as helpful on important psychosocial areas such as coping, emotional support, understanding and communication with others. Positive effects on quality of life were identified and significant, however, limited effects were noted on measurers related to distress, quality of life and impact of cancer.
Conclusions:
Conclusion: This guided internet-delivered intervention was well-received and feasible for women following primary treatment for gynecological cancer. Positive, but limited effects on quality of life were identified. The intervention should be tested in a larger group of women and other questionnaires focusing on health literacy, self-efficacy and/or empowerment are suggested. Clinical Trial: ClinicalTrials.gov (9612)
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.